Xenetic Biosciences Inc

NASDAQ XBIO

Data sourced from iex and EODHD
Download Data

Xenetic Biosciences Inc Income Statement 2011 - 2024

This table shows the Income Statement for Xenetic Biosciences Inc going from 2011 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30
Revenue
M 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 8 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 3 3 2 4 2 0 0 0 0 0 0 0 0 - 0 0 0 0 - 0 0 - -
Gross Profit
M 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - 0 0 0 8 7 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
M 2 2 2 2 2 2 1 3 2 2 2 1 2 1 11 1 1 1 - - - 2 2 2 9 3 2 3 3 3 2 43 2 3 4 1 4 4 3 3 3 0 0 0 0 0 0 0 0 0 0
Selling, General, and Administrative Expenses (SG&A)
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 2 1 2 2 2 1 2 1 2 3 1 1 1 1 2 2 0 0 0 0 0 0 0 0 0 0
Research and Development (R&D) Expenses
M 1 1 1 1 1 1 0 2 1 1 1 1 1 0 1 0 0 0 4 0 0 1 1 1 1 1 1 1 1 1 1 42 0 1 1 1 3 3 2 1 1 - - - - - - - - - -
Other Operating Expenses
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0 0 0 - - - 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - -
Costs and Expenses
M - - - - - - - - - - - - - - - - - - - - - 2 2 2 2 3 2 3 0 0 0 40 0 3 4 1 4 4 3 3 3 - 0 0 0 0 - 0 0 - -
Operating Income
M -1 -1 -1 -1 -1 -2 -1 -3 -2 -2 -1 -1 -1 -1 -11 -1 -1 -1 -9 -1 -1 -2 -2 -2 -2 4 -2 -3 -3 0 -2 -43 -2 -3 -4 -1 -4 -4 -3 -3 -3 0 0 0 0 0 0 0 0 0 0
Interest Expense
M - 0 - - 0 0 0 0 0 0 0 0 0 0 18 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Non-operating Income/Expense
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -9 0 0 0 -3 0 0 0 0 0 0 0 0 0 0 0 0 -4 -1 -1 -1 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0
EBT
M -1 -1 -1 -1 -1 -1 -1 -3 -2 -2 -1 -1 -1 -1 -10 -1 -1 -1 -9 -1 -1 -2 -2 -2 -2 4 -2 -3 -3 0 -2 -48 -4 -4 -5 -1 -4 -4 -3 -3 -4 0 0 0 0 0 0 0 0 0 0
Income Tax Provision
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -3 0 0 0 7 0 0 0 0 0 0 0 0 0 0 0 0 4 1 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 - 0
Income after Tax
M -1 -1 -1 -1 -1 -1 -1 -3 -2 -2 -1 -1 -1 -1 -8 -1 -1 -1 -15 -1 -1 -2 -2 -2 -2 4 -2 -3 -3 -1 -2 -52 -5 -4 -7 -1 -4 -4 -3 -3 -5 0 0 0 0 0 0 0 0 - 0
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 4 0 0 0 0 11 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 - 0 - - - - - - - -
Net Income
M - - - -1 -1 -1 -1 -3 -2 -2 -1 -1 -1 -1 -8 -1 -1 -1 -10 -1 -5 -2 -2 -2 -2 4 -2 -3 -3 -58 -2 -48 -4 -13 -5 -1 -2 -14 -3 -3 -4 - 0 - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 1,540,684.00 1,537,116.00 1,532,600.00 1,524,717.00 1,516,659.00 14,224,430.00 14,316,596.00 14,066,573.00 13,440,057.00 10,162,167.00 1,016,216.00 874,669.00 874,626.00 8,746,263.00 629,622.00 628,835.00 623,333.00 6,233,331.00 386,293.00 88,210.00 80,697.00 806,765.00 78,386.00 72,892.00 72,645.00 726,458.00 72,645.00 72,552.00 70,989.00 709,899.00 74,892.00 65,034.00 38,261.00 382,595.00 35,241.00 35,177.00 351,759.00 351,759.00 34,356.00 34,356.00 34,356.00 3,409.00 34,090.00 3,409.00 3,409.00 3,409.00 34,090.00 3,063.00 2,525.00 25,252.00 2,525.00
EBITDA
M -1 -1 -1 -1 -1 -2 -1 -3 -2 -2 -1 -1 -1 -1 8 -1 -1 -1 -2 -1 -1 -2 -2 -2 -2 4 -2 -3 -3 0 -2 -43 -2 -3 -4 -1 -4 -4 -3 -3 -3 0 0 0 0 0 0 0 0 0 0
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
EBIT
M -1 -1 -1 -1 -1 -2 -1 -3 -2 -2 -1 -1 -1 -1 8 -1 -1 -1 -2 -1 -1 -2 -2 -2 -2 4 -2 -3 -3 0 -2 -43 -2 -3 -4 -1 -4 -4 -3 -3 -3 0 0 0 0 0 0 0 0 0 0
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - -
Tax Rate (Effective)
% -0.89 -0.67 9.42 12.27 6.84 6.74 5.44 1.15 3.26 1.76 1.86 1.90 1.72 -0.24 27.85 3.02 4.35 5.52 -73.26 0.07 -0.01 0.02 0.13 -1.61 0.32 -0.33 -0.66 -0.87 -0.33 -73.45 4.91 -9.22 -41.29 -22.04 -26.20 9.78 -2.12 0.00 -2.29 -4.65 -26.33 -6.91 -18.27 -24.52 20.96 -22.08 -7.45 -8.32 -10.92 - -18.45
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - 0 - - - - - - - -
Gross Profit Margin
% 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 - - - - - - 100.00 99.21 -14.15 - - 100.00 - - - - - - - - - - - 100.00 -23.52 74.81 89.24 63.79 100.00 72.80 76.03 100.00 100.00
Operating Income Margin
% -248.31 -186.87 -187.62 -184.05 -151.06 -321.03 -204.66 -644.83 -416.39 -563.44 -393.97 -392.09 -715.99 -806.19 -9,060.68 -869.99 -2,168.82 -7,235.76 - - - - - - -24.38 59.08 -2,635.88 - - -2.15 - - - - - - - - - - - -3,539.28 773.60 -26.21 56.04 -34.23 -150.71 -97.79 -72.47 -72.47 -107.77
Net Income Margin
% - - - -161.44 -141.38 -215.82 -194.09 -641.26 -409.68 -553.72 -386.77 -384.79 -703.89 -792.98 -6,521.27 -844.48 -2,078.33 -6,857.18 - - - - - - -24.30 59.27 -2,654.00 - - -1,941.38 - - - - - - - - - - - - 954.93 - - - - - - - -
EBITDA Ratio
% -248.31 -186.87 -187.62 -184.05 -151.06 -321.03 -202.74 -642.53 -413.95 -560.65 -391.38 -389.04 -711.59 -800.87 6,890.24 -863.70 -2,155.75 -7,191.86 - - - - - - -24.30 59.33 -2,629.62 - - -1.84 - - - - - - - - - - - -2,696.36 625.10 -12.73 72.35 -18.11 -130.77 -83.21 -57.70 -57.70 -82.01
EBIT Ratio
% -246.23 -185.70 -188.87 -184.49 -153.19 -315.48 -204.66 -644.83 -416.39 -563.44 -393.97 -392.09 -715.99 -806.19 6,884.82 -869.99 -2,168.82 -7,235.76 - - - - - - -24.38 59.28 -2,635.88 - - -2.15 - - - - - - - - - - - -3,539.28 906.31 -26.21 56.04 -34.23 -150.71 -97.79 -72.47 -72.47 -107.77
EBT Ratio
% -233.96 -174.34 -172.71 -161.44 -141.38 -304.44 -194.09 -641.26 -409.68 -553.72 -386.77 -384.79 -703.89 -792.98 -9,038.67 -844.48 -2,078.33 -6,857.18 - - - - - - -24.30 59.27 -2,654.00 - - -13.04 - - - - - - - - - - - -3,801.84 946.51 -34.72 46.32 -43.92 -162.85 -106.66 -81.36 -81.36 -132.15

StockViz Staff

September 16, 2024

Any question? Send us an email